(19)
(11) EP 4 562 132 A2

(12)

(88) Date of publication A3:
04.04.2024

(43) Date of publication:
04.06.2025 Bulletin 2025/23

(21) Application number: 23847416.7

(22) Date of filing: 28.07.2023
(51) International Patent Classification (IPC): 
C12N 5/0783(2010.01)
C12N 15/62(2006.01)
A61K 35/17(2025.01)
C12N 5/10(2006.01)
(52) Cooperative Patent Classification (CPC):
C07K 14/7051; A61P 35/00; A61K 38/2013; A61K 38/2086; C12N 2510/00; C12N 2501/515; C12N 5/0636; A61K 40/35; A61K 40/4232; A61K 40/31; A61K 40/11
 
C-Sets:
  1. A61K 38/2013, A61K 2300/00;
  2. A61K 38/2086, A61K 2300/00;

(86) International application number:
PCT/US2023/029047
(87) International publication number:
WO 2024/026127 (01.02.2024 Gazette 2024/05)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 29.07.2022 US 202263393787 P

(71) Applicant: Adicet Therapeutics, Inc.
Redwood City, CA 94065 (US)

(72) Inventors:
  • AFTAB, Blake
    Redwood City, CA 94065 (US)
  • BHAT, Arun
    Redwood City, CA 94065 (US)
  • NISHIMOTO, Kevin
    Redwood City, CA 94065 (US)
  • TEAGUE, Alexander
    Redwood City, CA 94065 (US)
  • SPELTZ, Elizabeth
    Redwood City, CA 94065 (US)
  • LAMTURE, Gauri
    Redwood City, CA 94065 (US)
  • DING, Beibei
    Redwood City, CA 94065 (US)
  • RAMADOSS, Nitya
    Redwood City, CA 94065 (US)

(74) Representative: Mathys & Squire 
The Shard 32 London Bridge Street
London SE1 9SG
London SE1 9SG (GB)

   


(54) AFFINITY BINDING ENTITIES DIRECTED TO CD70 AND METHODS OF USE THEREOF